Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosis of chronic schizophrenic disorder, according to the Diagnostic and Statistical Manual of Mental Diseases, 3rd edition (DSM-III-R) criteria and are inpatients at the beginning of study~* total score on the PANSS (Positive and Negative Syndrome Scale for Schizophrenia) rating scale at study entry of \>=60 and \<=120~* females of childbearing age must demonstrate adequate birth control measures and have a negative pregnancy test before study entry.~Exclusion Criteria:~* Patients with mental disorders other than chronic schizophrenic disorder~* patients with clinically significant organic or neurological diseases~* patients with epilepsy~* history of alcohol or drug abuse history within the 6 months before study entry.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).